Welcome, Guest. Please login or register.
May 20, 2024, 05:34:25 pm

Login with username, password and session length


Members
  • Total Members: 6309
  • Latest: Vicki
Stats
  • Total Posts: 55126
  • Total Topics: 4851
  • Online Today: 100
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 82
Total: 82

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Hep C Could Become Rare in the U.S. By 2036 ... If We Test More, 2026.  (Read 6921 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Researchers recently created a mathematical model to predict how direct-acting antiviral (DAA) treatment and screening for the hep C virus will affect the future prevalence of the disease. Turns out testing has quite a lot to do with our ability to end the epidemic:

The model predicted that one-time hep C screening for baby boomers could identify 487,000 new cases of the virus over the next decade. With the availability of new drugs, hep C prevalence after that would be expected to plummet to just one in 1,500 people in the United States by 2036.

A one-time universal screen, on the other hand, could potentially identify 933,700 cases of hep C during that time frame -- and could lower hep C prevalence to the same level in just 12 years.

Read more: http://www.hepmag.com/articles/hep_C_rare_2501_26247.shtml

 


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.